Biogen Inc (BIIB)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$131.23
Buy
$131.27
$-0.79 (-0.60%)
Prices updated at 02 Apr 2025, 20:57 EDT
| Prices minimum 15 mins delay
Prices in USD
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
---|---|
2024 | 76.12 |
2023 | 74.24 |
2022 | 77.61 |
2021 | 80.79 |
2020 | 86.57 |
2019 | 86.40 |
2018 | 86.50 |
2017 | 86.72 |
2016 | 87.08 |
Valuation data table
Year | Price / Sales |
---|---|
2025 | 1.99 |
2024 | 2.32 |
2023 | 3.77 |
2022 | 3.92 |
2021 | 3.27 |
2020 | 2.87 |
2019 | 4.02 |
2018 | 4.74 |
2017 | 5.76 |
2016 | 5.46 |
2015 | 6.82 |
Price/Forward earnings (YTD)
8.40
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
---|---|
2024 | 5.95 |
2023 | 4.52 |
2022 | 12.58 |
2021 | 6.42 |
2020 | 15.43 |
2019 | 22.42 |
2018 | 18.11 |
2017 | 10.91 |
2016 | 17.47 |
Debt profile data table
Year | Financial leverage |
---|---|
2024 | 1.68 |
2023 | 1.81 |
2022 | 1.83 |
2021 | 2.19 |
2020 | 2.30 |
2019 | 2.04 |
2018 | 1.94 |
2017 | 1.88 |
2016 | 1.88 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.